Organon (Pharma)
Organon was a pharmaceutical company with its headquarters in Oss in the Netherlands until the end of 2007 . Organon was temporarily a subsidiary of Schering-Plow , which in 2009 was merged into MSD Sharp & Dohme (MSD). Organon is best known for developing the birth control pill . In 2006 the company achieved a turnover of 2.611 billion euros with around 14,000 employees worldwide.
history
Organon was founded in 1923 by Saal van Zwanenberg, a director of slaughterhouses. He was looking for a way to use slaughterhouse waste in a useful way. Together with Ernst Laqueur and Jacques van Oss, a method was found to extract the active substance insulin from the pancreas of pigs . This first Organon product was unique at the time.
Under the economic direction of Van Zwanenberg and the scientific direction of Laqueur, Organon grew into an international company that in 1934 was represented by sales offices in 40 countries. Organon currently has research facilities in 5 countries, manufacturing subsidiaries in 15 countries and sales offices in 50 countries. With a market of more than 100 countries, Organon is the largest pharmaceutical company in the Netherlands.
In 2002 part of the headquarters was relocated from Oss to Roseland in New Jersey ( USA ), where the center of the global pharmaceutical industry is located.
Organon was previously a subsidiary of Akzo Nobel ; In 2007 Organon was transferred to the American company Schering-Plow (transfer effective November 19, 2007), whose own existence in turn ended on November 7, 2009 when it was taken over by MSD.
On July 1, 2008, the Organon brand name disappeared from human medicine: the company and its products were fully integrated into Schering-Plow . Since Schering-Plow was not allowed to operate as Schering-Plow in Germany for trademark reasons, Organon went into the German market in Essex Pharma, which belongs to Schering-Plow . Schering-Plow was acquired by MSD in 2009.
Organon products
In addition to the production of insulin, Organon became known through Lyndiol (1962), one of the first birth control pills. The production in the predominantly Catholic Noord-Brabant was not easy: the resistance among the employees was initially so great that the packaging of the boxes was left to external companies. Later inventions include the Etonogestrel implant Implanon (1998), the vaginal ring Nuvaring (2003), the antidepressants Tolvin (1975, active ingredient Mianserin ) and Remergil (1996, active ingredient Mirtazapine ) as well as the neuroleptic Sycrest (2010, active ingredient Asenapine ).